CNET on MSN5d
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
Cold-and-flu remedies could be banned in US as experts say ingredient is not effective
Phenylephrine is the main decongestant ingredient in soluble and tablet-form cold-and-flu medicines such as Lemsip, Beechams, ...
ScienceAlert on MSN4d
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...
abc7NY7d
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
FiercePharma7d
FDA proposes ban on main ingredient in many OTC decongestants
Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be ...
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
Daily Mail8d
FDA wants to scrap Benadryl and Sudafed from pharmacies after finding drugs are useless against colds
The agency proposed on Thursday discontinuing the use of phenylephrine - an ingredient in common medications like Vicks Sinex, certain types of Sudafed and Benadryl - in nonprescription products ...
FDA proposes removing ineffective decongestant found in NyQuil, Benadryl, Sudafed and Mucinex
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral ...
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...